linagliptin [Ligand Id: 6318] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL237500 (BI 1356, BI-1356, BI 1356 BS, BI-1356-BS, BI-1356BS, BS 1356 BS, BS-1356-BS, Linagliptin, Tradjenta, Trajenta, Trazenta) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| Dipeptidyl peptidase 9 in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295538] [UniProtKB: E1BI31] | ||||||||
| ChEMBL | Inhibition of bovine DPP9 | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2017) 139: 482-491 [PMID:28826083] |
| Dipeptidyl-peptidase 7/Dipeptidyl peptidase II in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3976] [GtoPdb: 1605] [UniProtKB: Q9UHL4] | ||||||||
| ChEMBL | Inhibition of human DPP2 using Lys-Ala-AMC as substrate by fluorimetric analysis | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem (2012) 20: 5864-5883 [PMID:22938786] |
| ChEMBL | Inhibition of DPP2 in human seminal plasma using Lys-Ala-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition | B | 4 | pIC50 | >100000 | nM | IC50 | ACS Med Chem Lett (2013) 4: 491-496 [PMID:24900696] |
| ChEMBL | Inhibition of DPP2 purified from human seminal plasma using Lys-Ala-p-nitroanilide as substrate by spectrophotometry | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2014) 57: 3053-3074 [PMID:24617858] |
| ChEMBL | Binding affinity to DPP2 (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| ChEMBL | Inhibition of DPP2 (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| ChEMBL | Inhibition of QPP (unknown origin) preincubated for 30 mins followed by Nle-Pro-AMC addition measured for 50 mins by continuous fluorescence assay | B | 4 | pIC50 | >100000 | nM | IC50 | ACS Med Chem Lett (2016) 7: 498-501 [PMID:27190600] |
| ChEMBL | Inhibition of DPP2 (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2017) 139: 482-491 [PMID:28826083] |
| dipeptidyl peptidase 4/Dipeptidyl peptidase IV in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL284] [GtoPdb: 1612] [UniProtKB: P27487] | ||||||||
| ChEMBL | Binding affinity to human recombinant DPP4 (39 to 766 residues) at 5 uM by isothermal titration calorimetry | B | 8.28 | pKd | 5.3 | nM | Kd | J Med Chem (2016) 59: 7466-7477 [PMID:27438064] |
| GtoPdb | - | - | 9 | pKi | 1 | nM | Ki | J Med Chem (2007) 50: 6450-3 [PMID:18052023] |
| ChEMBL | Binding affinity to DPP4 (unknown origin) | B | 8.7 | pIC50 | 2 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| ChEMBL | Inhibition of DPP4 in human seminal plasma using Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition | B | 8.7 | pIC50 | 2 | nM | IC50 | ACS Med Chem Lett (2013) 4: 491-496 [PMID:24900696] |
| ChEMBL | Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (2014) 57: 3053-3074 [PMID:24617858] |
| ChEMBL | Inhibition of human DPP4 | B | 8.7 | pIC50 | 2 | nM | IC50 | Eur J Med Chem (2017) 139: 482-491 [PMID:28826083] |
| ChEMBL | Inhibition of human recombinant DPP-4 using (H-Gly-Pro-AMC as substrate | B | 8.9 | pIC50 | 1.25 | nM | IC50 | Bioorg Med Chem (2021) 46: 116354-116354 [PMID:34428715] |
| ChEMBL | Inhibition of human DPP4 in pH 7.4 Tris buffer using AP-7-ATFMC as substrate preincubated for 15 mins followed by substrate addition by microplate reader analysis | B | 8.9 | pIC50 | 1.25 | nM | IC50 | Eur J Med Chem (2020) 187: 111912-111912 [PMID:31812034] |
| ChEMBL | DPP-IV Activity InhibitoryAssay: Gly-Pro-7-amido-4-methylcoumarin can be hydrolyzed by dipeptidyl peptidase IV (DPP-IV) at room temperature, to generate 7-amido-4-methyl coumarin, which can emit fluorescence with wavelength of 460 nm at excitation wavelength of 355 nm. The variation of the product amount can be determined by the variation of fluorescence intensity, so as to reflect the activity level of the enzyme. The dipeptidyl peptidase IV (DPP-IV), DPP-IV buffer and test samples were used to construct the reaction system of 200 uL, while the blank control (without enzyme and samples) and negative control (without samples) having the same volume were set up. The reaction system and the controls were reacted at room temperature for 10 min, and then dipeptidyl peptidase IV substrate was added thereto respectively, then reacted at room temperature for 30 min. The fluorescence intensity F (excitation wavelength of 355 nm, emission wavelength of 460 nm) was determined. | B | 9 | pIC50 | 1 | nM | IC50 | US-9255098-B2. Xanthine derivative (2016) |
| ChEMBL | DPP-IV Assay: 50 ÎĽl substrate solution (AFC; AFC is amido-4-trifluoromethylcoumarin), final concentration 100 ÎĽM, were placed in black microtitre plates. 20 ÎĽl of assay buffer (final concentrations 50 mM Tris HCl pH 7.8, 50 mM NaCl, 1% DMSO) was pipetted in. The reaction was started by adding 30 ÎĽl of solubilised Caco-2 protein (final concentration 0.14 ÎĽg of protein per well). The test substances to be investigated were typically added prediluted in 20 ÎĽl, and the volume of assay buffer was then reduced accordingly. The reaction was carried out at ambient temperature, incubating for 60 minutes. Then the fluorescence was measured in a Victor 1420 Multilabel Counter, the excitation wavelength being 405 nm and the emission wavelength being 535 nm. Blank readings (corresponding to 0% activity) were obtained in mixtures without any Caco-2 protein (volume replaced by assay buffer), control values (corresponding to 100% activity) were obtained in mixtures with no substance added. | B | 9 | pIC50 | 1 | nM | IC50 | US-9321791-B2. 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions (2016) |
| ChEMBL | Inhibition of human DPP4 | B | 9 | pIC50 | 1 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| ChEMBL | Inhibition of DPP4 in human Caco-2 cells after 1 hr | B | 9 | pIC50 | 1 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 3158-3162 [PMID:18485703] |
| ChEMBL | Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis | B | 9 | pIC50 | 1 | nM | IC50 | Bioorg Med Chem (2012) 20: 5864-5883 [PMID:22938786] |
| ChEMBL | Inhibition of dipeptidyl peptidase 4 (unknown origin) | B | 9 | pIC50 | 1 | nM | IC50 | Med Chem Res (2013) 22: 4505-4521 |
| ChEMBL | Inhibition of DPP4 in human Caco2 cells using H-Ala-Pro-7-amido-4-trifluoromethylcoumarin as substrate after 1 hr by fluorescence assay | B | 9 | pIC50 | 1 | nM | IC50 | Bioorg Med Chem (2013) 21: 2795-2825 [PMID:23623674] |
| ChEMBL | Inhibition of human DPP4 in Caco-2 cells by fluorescene assay | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (2007) 50: 6450-6453 [PMID:18052023] |
| ChEMBL | Inhibition of human recombinant DPP4 (39 to 766 residues) using Ala-Pro-AFC as substrate incubated for 1 hr by fluorescence assay | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (2016) 59: 7466-7477 [PMID:27438064] |
| ChEMBL | Inhibition of DPP4 (unknown origin) | B | 9 | pIC50 | 1 | nM | IC50 | Eur J Med Chem (2021) 211: 113016-113016 [PMID:33243532] |
| ChEMBL | Inhibition of human DPP4 using Gly-Pro-AMC as substrate incubated for 30 mins by continuous fluorescent assay | B | 9.4 | pIC50 | 0.4 | nM | IC50 | Bioorg Med Chem Lett (2022) 76: 129018-129018 [PMID:36209967] |
| ChEMBL | Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system | B | 10 | pIC50 | 0.1 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 1464-1468 [PMID:22177783] |
| ChEMBL | Inhibition of human DPP4 preincubated for 30 mins followed by Gly-Pro-AMC addition measured for 50 mins by continuous fluorescence assay | B | 10 | pIC50 | 0.1 | nM | IC50 | ACS Med Chem Lett (2016) 7: 498-501 [PMID:27190600] |
| dipeptidyl peptidase 9/Dipeptidyl peptidase IX in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4793] [GtoPdb: 2357] [UniProtKB: Q86TI2] | ||||||||
| ChEMBL | Binding affinity to DPP9 (unknown origin) | B | 4 | pIC50 | 100000 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| ChEMBL | Inhibition of DPP9 (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| ChEMBL | Inhibition of DPP9 (unknown origin) preincubated for 20 mins followed by Gly-Pro-AMC addition measured for 50 mins by continuous fluorescence assay | B | 4 | pIC50 | >100000 | nM | IC50 | ACS Med Chem Lett (2016) 7: 498-501 [PMID:27190600] |
| ChEMBL | Inhibition of DPP9 | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem (2012) 20: 5864-5883 [PMID:22938786] |
| dipeptidyl peptidase 8/Dipeptidyl peptidase VIII in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4657] [GtoPdb: 2356] [UniProtKB: Q6V1X1] | ||||||||
| ChEMBL | Inhibition of recombinant DPP8 (unknown origin) preincubated for 20 mins followed by Ala-Pro-AFC addition measured for 40 mins by continuous fluorescence assay | B | 4 | pIC50 | >100000 | nM | IC50 | ACS Med Chem Lett (2016) 7: 498-501 [PMID:27190600] |
| ChEMBL | Inhibition of DPP8 (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2017) 139: 482-491 [PMID:28826083] |
| ChEMBL | Inhibition of DPP8 | B | 4.4 | pIC50 | >40000 | nM | IC50 | Bioorg Med Chem (2012) 20: 5864-5883 [PMID:22938786] |
| ChEMBL | Inhibition of DPP8 (unknown origin) | B | 4.4 | pIC50 | >40000 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| fibroblast activation protein alpha/Fibroblast activation protein alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4683] [GtoPdb: 2365] [UniProtKB: Q12884] | ||||||||
| ChEMBL | Binding affinity to FAP (unknown origin) | B | 6.43 | pIC50 | 370 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| ChEMBL | Inhibition of FAPalpha | B | 7.05 | pIC50 | 89 | nM | IC50 | Bioorg Med Chem (2012) 20: 5864-5883 [PMID:22938786] |
| ChEMBL | Inhibition of FAP (unknown origin) | B | 7.05 | pIC50 | 89 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| ChEMBL | Inhibition of FAP (unknown origin) preincubated for 20 mins followed by Nle-Pro-AMC addition measured for 40 mins by continuous fluorescence assay | B | 7.15 | pIC50 | 70.8 | nM | IC50 | ACS Med Chem Lett (2016) 7: 498-501 [PMID:27190600] |
| Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
| ChEMBL | Inhibition of human ERG by dofetilide binding assay | B | 4.52 | pIC50 | >30000 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 1464-1468 [PMID:22177783] |
| M1 receptor/Muscarinic acetylcholine receptor M1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL216] [GtoPdb: 13] [UniProtKB: P11229] | ||||||||
| ChEMBL | Inhibition of M1 receptor (unknown origin) | B | 6.52 | pIC50 | 300 | nM | IC50 | J Med Chem (2016) 59: 7466-7477 [PMID:27438064] |
| ChEMBL | Displacement of [N-methyl-3H]scopolamine from human recombinant muscarinic M1 receptor expressed in CHO cells | B | 6.53 | pIC50 | 295 | nM | IC50 | J Med Chem (2007) 50: 6450-6453 [PMID:18052023] |
| ChEMBL | Inhibition of M1 receptor | B | 6.53 | pIC50 | 295 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 1464-1468 [PMID:22177783] |
| prolyl endopeptidase/Prolyl endopeptidase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3202] [GtoPdb: 2395] [UniProtKB: P48147] | ||||||||
| ChEMBL | Inhibition of human recombinant PREP expressed in Escherichia coli using Z-Gly-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition | B | 4 | pIC50 | >100000 | nM | IC50 | ACS Med Chem Lett (2013) 4: 491-496 [PMID:24900696] |
| ChEMBL | Inhibition of recombinant human PREP purified from Escherichia coli using Z-Gly-Pro-p-nitroanilide as substrate by spectrophotometry | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2014) 57: 3053-3074 [PMID:24617858] |
| ChEMBL | Binding affinity to PREP (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| ChEMBL | Inhibition of PREP (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | Medchemcomm (2014) 5: 1700-1707 |
| fibroblast activation protein alpha/Seprase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5769] [GtoPdb: 2365] [UniProtKB: P97321] | ||||||||
| ChEMBL | Inhibition of mouse recombinant FAP expressed in HEK293 cells using Ala-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition | B | 6.43 | pIC50 | 370 | nM | IC50 | ACS Med Chem Lett (2013) 4: 491-496 [PMID:24900696] |
| ChEMBL | Inhibition of recombinant mouse FAP purified from HEK293 cell supernatant using Ala-Pro-p-nitroanilide as substrate by spectrophotometry | B | 6.43 | pIC50 | 370 | nM | IC50 | J Med Chem (2014) 57: 3053-3074 [PMID:24617858] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
